603998.SS SHH
Hunan Fangsheng Pharmaceutical Co., Ltd.
1W: -1.5%
1M: -3.6%
3M: +10.3%
YTD: -16.6%
1Y: -4.2%
3Y: +3.1%
5Y: +94.4%
¥10.36 ($1.54)
+0.10 (+0.97%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥4.5B ($678.3M)
52W Range8.64-13.5
Volume6,771,400
Avg Volume10,746,000
Beta0.28
Dividend¥0.45
Analyst Ratings
No analyst coverage
Company Info
CEOXiaoli Zhou
Employees1,868
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2014-12-05
Websitefangsheng.com.cn
No. 299, Jiayun Road
Changsha, HU 410205
CN
Changsha, HU 410205
CN
86 731 8899 7188
About Hunan Fangsheng Pharmaceutical Co., Ltd.
Operating within China, Hunan Fangsheng Pharmaceutical Co., Ltd. is engaged in the complete spectrum of pharmaceutical activities, from research and development to manufacturing and sales. Its diverse product line encompasses tablets, capsules, and granules, addressing a wide array of therapeutic areas such as cardiovascular, cerebrovascular, orthopedic, pediatric, gynecological, traumatology, and anti-infective conditions. The company was established in 2002 and is headquartered in Changsha, China.
Latest News
No recent news
Recent Insider Trades
No insider trades found